Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX6NDG
|
||||
Drug Name |
4-{5-[4-(3-Chloro-phenyl)-3-oxo-piperazin-1-ylmethyl]-imidazol-1-ylmethyl}-2-(5,6,7,8-tetrahydro-naphthalen-2-yloxy)-benzonitrile
|
||||
Synonyms |
CHEMBL29769
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C32H30ClN5O2
|
||||
Canonical SMILES |
Clc1cccc(c1)N2CCN(Cc3cncn3Cc4ccc(C#N)c(Oc5ccc6CCCCc6c5)c4)CC2=O
|
||||
InChI |
InChI=1S/C32H30ClN5O2/c33-27-6-3-7-28(16-27)38-13-12-36(21-32(38)39)20-29-18-35-22-37(29)19-23-8-9-26(17-34)31(14-23)40-30-11-10-24-4-1-2-5-25(24)15-30/h3,6-11,14-16,18,22H,1-2,4-5,12-13,19-21H2
|
||||
InChIKey |
DRVXNKXBSICBHX-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.